RxSearch

NDC properties for "Cyltezo Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count)" (RxCUI 2680757)

About this data

The tables show NDC propoerties for Cyltezo Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count) with the RxCUI 2680757

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product

Details for Cyltezo Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count) (RxCUI 2680757)

BLABLA761058
MMSL_CODEBD40586
RxCUI2680757
SPL_SET_ID115ea79b-7209-7f19-b35d-36ec0828fbf5
Prescribable SynonymCYLTEZO Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count)
RXNAV_STRCyltezo Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count)
RxNorm Name{4 (0.4 ML adalimumab-adbm 100 MG/ML Auto-Injector [Cyltezo]) } Pack [Cyltezo Pen 40 MG/0.4 ML Starter Pack - Psoriasis]
RxNorm SynonymCyltezo Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count)
Related queriesInteractions (for RxCUI 2680757)



NDC Properties

NDC Item 00597049540

NDC 90597-0495
NDC 100597-0495-40
NDC Item00597049540
Packaging4 KIT in 1 CARTON (0597-0495-40) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0490-32) / .4 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET
BLABLA761058
FDA SPL set id784444
LabelerBoehringer Ingelheim Pharmaceuticals, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryBLA
Marketing effective time low2024-04-30
Marketing statusACTIVE
Related queriesProperties for NDC 9 0597-0495